Advisory Research Inc Immunocore Holdings PLC Transaction History

Advisory Research Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$49.5 - $66.6 $40,194 - $54,079	812 Added 3.32%	25,276 $1.31 Million
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $197,703 - $251,059	4,073 Added 19.97%	24,464 $1.47 Million
Q1 2023 May 12, 2023	SELL	$46.12 - $65.71 $46,581 - $66,367	-1,010 Reduced 4.72%	20,391 $1.01 Million
Q4 2022 Feb 13, 2023	SELL	$45.51 - $65.08 $262,592 - $375,511	-5,770 Reduced 21.24%	21,401 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $1.01 Million - $1.56 Million	27,171 New	27,171 $1.28 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.